A new standard in research. A world of possibility.Discover the Peptivia standard

Collection / Sermorelin

PEPTIVIASermorelin10 mgVIAL · RESEARCH USE ONLY
Growth-axis research · vial

Sermorelin

Sermorelin is a GHRH (1–29) analogue used to explore growth-hormone-releasing signals. Its fragment identity offers a clear comparison with other growth-axis peptides.

$109.99 CAD

Simulation only · No real order or payment.

BrandPEPTIVIA
Format / strengthvial · 10 mg
Pack quantity1

GHRH (1–29) analogue

Also known as: GRF 1-29

Evidence review pending
Research & handling

Not for human or veterinary use. Storage, handling, identity and purity require verified batch documentation. No dosing or treatment advice is provided.

RESEARCH FOCUS

At a glance

GHRH pathway

A releasing-hormone analogue is distinct from growth hormone itself.

Fragment comparison

Its 1–29 identity differs from long-acting DAC-modified CJC-1295.

Explore the study context and sources below. For laboratory research only.

EXPLORE THE EVIDENCE

Studies & context

Sermorelin is a GHRH (1–29) analogue. It is not growth hormone and is distinct from long-acting CJC-1295.

Evidence review pending

No reviewed study findings are supplied for this exact identity.

Published research is separate from PEPTIVIA identity, content, purity, sterility and batch documentation. No source-supplier report verifies PEPTIVIA material.